Navigation Links
CardioVascular BioTherapeutics Submits FDA Application for 'Fast Track' Status for CVBT-141B, CVBT's Biological Treatment for Diabetes Patients
Date:2/3/2011

LAS VEGAS, Feb. 3, 2011 /PRNewswire/ -- CardioVascular BioTherapeutics, Inc. (Pink Sheets: CVBT) today announced it has submitted an application to the U.S. FDA to obtain "fast track" designation for CVBT-141B, its biological therapy to treat ischemic diabetic wounds based on the active ingredient fibroblast growth factor-1 (FGF-1).  The FDA grants "fast track" designation to accelerate the development of promising new therapies that treat a serious medical condition and for which there are no available therapies that adequately address the problem.

CVBT believes CVBT-141B meets the FDA's criteria, as ischemic diabetic wounds, if not successfully treated, can lead to infection, sepsis, amputation, and death.  Even with currently-available treatments, there are more than 80,000 foot amputations per year in the diabetic patient population.  CVBT-141B is targeted at reducing the suffering in the diabetes community by closing ischemic diabetic wounds much more rapidly, thereby halting the all-too-common progression to infection, gangrene, amputation, and death.

CVBT's CEO, Daniel C. Montano, stated, "This is a major development for CVBT's ischemic diabetic wound healing program as well as for diabetes patients.  The Centers for Disease Control and Prevention (CDC) reports that approximately 26 million Americans suffer from diabetes, while published peer-reviewed statistics indicate that 15% to 25% of these patients (3.9 million to 6.5 million patients) will eventually develop a diabetic foot wound at some point in their lifetime(i). Further, additional published peer-reviewed statistics indicate that in any given year, between 2% and 5% of diabetes patients (520,000 to 1.3 million patients annually) will develop one of these wounds(ii). Ischemic diabetic wounds are the most difficult of to heal. This is a life-threatening health problem for which there
'/>"/>

SOURCE CardioVascular BioTherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
2. Reportlinker Adds Europe Cardiovascular Devices Market Outlook to 2016
3. Prescient Medical, Inc. Presenting at the 5th Annual Canaccord Genuity Cardiovascular Conference
4. Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
5. InfraReDx to Present at Canaccord Genuity 5th Annual Cardiovascular, Diabetes & Obesity Conference
6. BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States
7. Study Highlights Incidence of Cardiovascular Disease-Related Events and All-Cause Hospitalizations Associated with BYETTA® Compared to Insulin, Thiazolidinediones, Sulfonylureas, Metformin and Januvia®
8. NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events
9. Reportlinker Adds Cardiovascular Surgical Devices: The Global Market
10. Beaumont Hospital Opens New Ernst Cardiovascular Center
11. Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015   ICD-10 Charts ... months of development, it has officially launched its ... Charts Training Academy and the new 4 Step ... well as all other ICD-10 Charts resources and ... in America, completely free-of-charge.  With the release of ...
(Date:7/7/2015)... 2015 Research and ... the "Elemental Analysis Market by Type (Organic, ... Application (Life Sciences, Food and Beverage Testing, Environment ... report to their offering. The ... types, technologies, and applications. By type, the market ...
(Date:7/7/2015)... and FREMONT, Calif. , July 7, ... South Korea and Velos, Inc. have entered into ... eResearch for cancer research nationally throughout South Korea ... The recent agreement signing was accompanied by a two day ... , South Korea.  National Cancer Center President ...
Breaking Medicine Technology:ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 2ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 3ICD-10 Charts Releases Revolutionary Free Solution for Complete ICD-10 Preparation 4Elemental Analysis (Organic, Inorganic) Market 2015 - Analysis & Global Forecasts to 2020 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 3
... Oct. 6 According to Millennium Research Group ... intelligence, growth in the $2 billion US cardiac ... the expanded approval of Boston Scientific,s chronic resynchronization ... I and II patients. The New ...
... Oct. 6 e-MDs, an industry leader in ... (EHRs) and practice management (PM) solutions,  congratulates  the ... Family Medicine of Fort Collins, CO, for their ... of Excellence recipients.  The Healthcare Information and Management ...
Cached Medicine Technology:Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 2Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 3e-MDs Clients Win HIMSS Davies Awards of Excellence 2e-MDs Clients Win HIMSS Davies Awards of Excellence 3e-MDs Clients Win HIMSS Davies Awards of Excellence 4
(Date:7/7/2015)... Angeles, CA (PRWEB) , ... July 07, 2015 ... ... International Business Times highlights rumors about possible facial rejuvenation that have emerged about ... year-old former U.S. Secretary of State looks more youthful than she has in ...
(Date:7/7/2015)... ... 07, 2015 , ... Greatist today announced the acquisition of ... find the most fun activities to do with friends. , The acquisition of BSC ... Greatist’s opportunity for events, e-commerce, and brand partnerships. , “I’ve been a huge fan ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... whose board is limited to permit holders. The Medical Cannabis Alliance of Illinois’ ... the industry forward and are committed to making sure patients have access to ...
(Date:7/7/2015)... ... July 07, 2015 , ... At the end of June Pacific Prime Renewals team in ... . This initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not only reduce ... On this initiative Cotton explained, “We send anything between 300 and 600 pieces of paper ...
(Date:7/7/2015)... ... July 07, 2015 , ... The Immune ... for its patient community using its IDF ePHR, an electronic personal health record ... diseases (PI) to easily track their health information, including symptoms, diagnoses, medications, infusions ...
Breaking Medicine News(10 mins):Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
... HealthDay Reporter , TUESDAY, Jan. 11 (HealthDay News) -- Over ... blood pressure drug candesartan stood a higher chance of survival ... fact, 61 percent of those taking candesartan (Atacand) survived, compared ... may be due to differences in the way the drugs ...
... , TUESDAY, Jan. 11 (HealthDay News) -- Jane Adrian, 61, ... two co-workers suffer from the painful, blistering condition known as ... , Even though the vaccine is only about 55 ... feel relieved." A study of a cross-section of ...
... Reporter , TUESDAY, Jan. 11 (HealthDay News) -- Arizona Congresswoman ... said, three days after she was struck in the brain ... said doctors left a breathing tube in the 40-year-old woman ... her own, is alert and responding to doctors, the ...
... Researchers from Boston University School of Medicine (BUSM), ... from Denmark and Germany, have found that 5a-reductase ... with benign prostatic hyperplasia (BPH) and possible hair ... individuals including loss of libido, erectile dysfunction (ED), ...
... imaging and therapy have earned Eric Wickstrom, Ph.D., ... Medical College of Thomas Jefferson University and member of ... peers as a 2010 Fellow of the American Association ... honoring Dr. Wickstrom for his "distinguished contributions to genetic ...
... , TUESDAY, Jan. 11 (HealthDay News) -- The total ... $270 billion per year while the cost in Canada is about ... billion total cost in the United States and Canada is the ... worker productivity due to higher rates of death ($49 billion); loss ...
Cached Medicine News:Health News:Not All Heart Failure Drugs Boost Survival Equally 2Health News:Shingles Vaccine Looks Like a Safe Bet for Seniors: Study 2Health News:Shingles Vaccine Looks Like a Safe Bet for Seniors: Study 3Health News:Wounded Congresswoman Breathing on Her Own: Report 2Health News:Wounded Congresswoman Breathing on Her Own: Report 3Health News:Wounded Congresswoman Breathing on Her Own: Report 4Health News:Drugs for hair loss and BPH may result in loss of libido, ED in men 2Health News:Cost of Obesity Approaching $300 Billion a Year 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: